Patents by Inventor Xinyi GUO

Xinyi GUO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-HELICOBACTER PYLORI DERIVATIVE CONTAINING DIHYDROSTILBENE PARENT NUCLEUS AND PREPARATION METHOD AND APPLICATION THEREOF
    Publication number: 20240366546
    Abstract: The invention belongs to the field of medicine, and particularly discloses an anti-Helicobacter pylori derivative containing a dihydrostilbene parent nucleus and a preparation method thereof; according to the invention, glycyrrhiza stems and leaves are used as raw materials, subjected to alcohol extraction, and then extracted, separated and identified through a macroporous resin, silica gel column chromatography and a preparative liquid phase to obtain a new natural isopentenyl dihydrostilbene compound, and the new compound has good activity to two kinds of drug-resistant and sensitive Helicobacter pylori, and can be used for preparing an anti-Helicobacter pylori drug.
    Type: Application
    Filed: June 10, 2024
    Publication date: November 7, 2024
    Applicant: NANJING UNIVERSITY OF CHINESE MEDICINE
    Inventors: Jinao DUAN, Ming ZHAO, Junfei ZHOU, Hui YAN, Sheng GUO, Shulan SU, Xinyi WEI, Hongkai BI
  • Use of phosphorylated heptose compounds
    Patent number: 12036229
    Abstract: Phosphorylated heptose compounds are useful in modulating an immune response in a subject. Also, the compounds are useful as adjuvants.
    Type: Grant
    Filed: May 11, 2018
    Date of Patent: July 16, 2024
    Assignees: National Research Council of Canada, The Governing Council of the University of Toronto
    Inventors: Andrew Cox, Janelle Sauvageau, Scott Gray-Owen, Xinyi Guo
  • D-glycero-B-D-heptose 1-phosphate (HMP) conjugates and use for targeted immune modulation
    Patent number: 11795190
    Abstract: Heptose-1-monophosphate-7-derivatives are modifiable immunomodulators that can be used to prepare clinically active conjugate compounds. Such conjugate compounds are useful in modulating an immune response in a subject.
    Type: Grant
    Filed: December 29, 2018
    Date of Patent: October 24, 2023
    Assignees: NATIONAL RESEARCH COUNCIL OF CANADA, THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO
    Inventors: Janelle Sauvageau, Andrew Cox, Xinyi Guo, Scott Gray-Owen
  • D-GLYCERO-B-D-HEPTOSE 1-PHOSPHATE (HMP) CONJUGATES AND USE FOR TARGETED IMMUNE MODULATION
    Publication number: 20200331949
    Abstract: Heptose-1-monophosphate-7-derivatives are modifiable immunomodulators that can be used to prepare clinically active conjugate compounds. Such conjugate compounds are useful in modulating an immune response in a subject.
    Type: Application
    Filed: December 29, 2018
    Publication date: October 22, 2020
    Inventors: Janelle SAUVAGEAU, Andrew COX, Xinyi GUO, Scott GRAY-OWEN
  • USE OF PHOSPHORYLATED HEPTOSE COMPOUNDS
    Publication number: 20200268774
    Abstract: Phosphorylated heptose compounds are useful in modulating an immune response in a subject. Also, the compounds are useful as adjuvants.
    Type: Application
    Filed: May 11, 2018
    Publication date: August 27, 2020
    Applicants: NATIONAL RESEARCH COUNCIL OF CANADA, THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO
    Inventors: Andrew COX, Janelle SAUVAGEAU, Scott GRAY-OWEN, Xinyi GUO